Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 336 Myelodysplastic Syndromes 147 Leukemia, Myelomonocytic, Chronic 68 Leukemia 60 Recurrence 28 Myeloproliferative Disorders 20 Neoplasms 19 Hematologic Neoplasms 17 Lymphoma, Non-Hodgkin 16 Lymphoma 16 Carcinoma, Non-Small-Cell Lung 16 Multiple Myeloma 14 Anemia, Refractory, with Excess of Blasts 14 Lymphoma, T-Cell, Peripheral 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Neoplasm, Residual 12 Lymphoma, Large B-Cell, Diffuse 12 Leukemia, Lymphocytic, Chronic, B-Cell 11 Leukemia, Biphenotypic, Acute 11 Primary Myelofibrosis 10 Leukemia, Monocytic, Acute 9 Hodgkin Disease 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Myelodysplastic-Myeloproliferative Diseases 8 Leukemia, Myelomonocytic, Acute 8 Leukemia, Erythroblastic, Acute 8 Breast Neoplasms 8 Neoplasm Metastasis 7 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7

Interventions

Temozolomide 140 Bevacizumab 63 Radiotherapy 54 Magnetic Resonance Spectroscopy 52 Irinotecan 27 Carboplatin 23 Surgical Procedures, Operative 18 Radiation 18 Carmustine 18 Specimen Handling 17 Nivolumab 16 Lomustine 15 Biopsy 15 Aminolevulinic Acid 15 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 Cyclophosphamide 12 trametinib 11 Topotecan 11 Radiosurgery 11 Erlotinib Hydrochloride 11 fluorodopa F 18 9 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡